Tetanus
📧 Sign up to get email alerts when something new happens for Tetanus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-02-12Clinical Trial Update: Immunogenicity of a Single Dose of GSK Biologicals' Boostrix™ in Infants Prior to Primary Pertussis Vaccination, When Administered to Pregnant Women as Per Routine Practice in Bogota, Colombia [Phase 4]
Phase 4 trial update evaluating the immunogenicity of a single Boostrix dose in infants prior to primary pertussis vaccination when administ…
-
CLINICAL_TRIALS trial_result · 2019-01-28Clinical Trial Update: Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Pregnant Women [Phase 4]
Phase 4 trial assessing immunogenicity and safety of Boostrix vaccine in pregnant women has completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-01-25Clinical Trial Update: Immunogenicity and Safety Study in Infants of GlaxoSmithKline Biologicals' Infanrix Hexa™ (DTPa-HBV-IPV/Hib) Vaccine [Phase 3]
Phase 3 immunogenicity and safety study of Infanrix Hexa in infants completed; results posted.
-
CLINICAL_TRIALS trial_result · 2019-01-15Clinical Trial Update: Immunogenicity & Reactogenicity of Boostrix 10 Years After Previous Booster Vaccination in Study NCT01267058 [Phase 4]
A Phase 4 clinical trial update evaluating immunogenicity and reactogenicity of Boostrix ten years after prior booster vaccination.
-
CLINICAL_TRIALS trial_result · 2018-10-29Clinical Trial Update: Evaluation of the Immunogenicity, Safety and Reactogenicity of the Combined DTPa-IPV Vaccine in Healthy Infants [Phase 3]
Phase 3 clinical trial update on the immunogenicity, safety and reactogenicity of the combined DTPa-IPV vaccine in healthy infants; results …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-09-17Clinical Trial Update: Immunogenicity, Safety of GSKs Tdap Vaccine Boostrix When Coadministered With GSKs Influenza Vaccine Fluarix in Adults [Phase 3]
Phase 3 trial assessing immunogenicity and safety of coadministering GSK Tdap vaccine Boostrix with GSK influenza vaccine Fluarix in adults.
-
CLINICAL_TRIALS trial_result · 2018-09-17Clinical Trial Update: Response to GSK Biologicals' Tritanrix-HepB/Hib-MenAC Vacc (4th Dose) at 15-24m & Mencevax ACWY at 24-30m [Phase 3]
Phase 3 trial update of Tritanrix-HepB/Hib-MenAC and Mencevax ACWY vaccines with completed status and results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-08-15Clinical Trial Update: Safety Study of a Vaccine Against Meningitis in Infants (2,4 & 6 Months Age) After a Birth Dose of Hepatitis B. [Phase 3]
Phase 3 safety study evaluating a vaccine against meningitis in infants following a birth dose of hepatitis B; the trial is completed.
-
CLINICAL_TRIALS trial_result · 2018-08-10Clinical Trial Update: Immunogenicity and Safety of BoostrixTM Using a New Syringe in 10 to 15-year Old Adolescents [Phase 4]
A Phase 4 trial assessing immunogenicity and safety of Boostrix using a new syringe in adolescents aged 10 to 15 years; results completed an…
-
CLINICAL_TRIALS trial_result · 2018-08-07Clinical Trial Update: Safety and Immunogenicity of GSK's Tdap Vaccine (Boostrix) in Adults Aged 19 to 64 Years [Phase 3]
Phase 3 trial assessing safety and immunogenicity of GSK Boostrix (Tdap) in adults 19–64; completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-08-01Clinical Trial Update: Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants [Phase 3]
A Phase 3 trial assessing immunogenicity and safety of GSK Infanrix Hexa given at 2, 4, and 6 months in healthy infants; study completed wit…
-
CLINICAL_TRIALS trial_result · 2018-06-12Clinical Trial Update: Antitetanus Vaccination for People Older Than 65 Years.
A completed clinical trial evaluated antitetanus vaccination in people older than 65 years.
-
CLINICAL_TRIALS trial_result · 2018-06-11Clinical Trial Update: Immunogenicity and Safety of a Tetanus-diphtheria Vaccine and a 13-valent Pneumococcal Conjugate Vaccine [Phase 4]
Phase 4 trial assessed immunogenicity and safety of a tetanus-diphtheria vaccine given with a 13-valent pneumococcal conjugate vaccine; the …
-
CLINICAL_TRIALS trial_result · 2018-03-19Clinical Trial Update: Immunogenicity and Safety Study of Proquad® and Infanrix® Hexa When Administered Concomitantly (V221-035) [Phase 3]
Phase 3 immunogenicity and safety study assessing concomitant administration of ProQuad and Infanrix Hexa has been completed and results pos…
-
CLINICAL_TRIALS trial_result · 2017-12-27Clinical Trial Update: Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Previously Boosted Young Adults [Phase 3]
Phase 3 results show immunogenicity and safety of GlaxoSmithKline's Boostrix Tdap vaccine in previously boosted young adults.
-
CLINICAL_TRIALS withdrawal · 2017-12-26Clinical Trial Update: Evaluation of Immunogenicity and Safety of DTPa-IPV/Hib Conjugate Vaccine (Infanrix™-IPV/Hib) Administered at 6, 10 and 14 Weeks in Healthy Indian Infants [Phase 3]
Phase 3 trial evaluating immunogenicity and safety of Infanrix-IPV/Hib (DTPa-IPV/Hib) in healthy Indian infants has been withdrawn.
-
CLINICAL_TRIALS research · 2017-11-17Clinical Trial Update: Mobile Phone SMS Messages and Automated Calls in Improving Vaccine Coverage Among Children in Pakistan [NA]
This clinical trial update from Aga Khan University evaluates whether mobile phone SMS messages and automated calls can improve vaccine cove…
-
CLINICAL_TRIALS trial_result · 2017-10-13Clinical Trial Update: Assessment of Intra-subject Variability in the Bioavailability of Chlorpromazine Hydrochloride [Phase 1]
Phase 1 study assessing intra-subject variability in the bioavailability of chlorpromazine hydrochloride. The study is completed and results…
-
CLINICAL_TRIALS trial_result · 2017-10-09Clinical Trial Update: Safety and Immunogenicity in Adults of Revaccination With Adacel® Vaccine 10 Years After a Previous Dose [Phase 4]
Phase 4 trial assessing safety and immunogenicity of Adacel booster given 10 years after prior dose in adults.
-
CLINICAL_TRIALS trial_result · 2017-09-11Clinical Trial Update: REVAXIS® Versus DT Polio® as a Second Booster in 6 Year-old Children [Phase 3]
Phase 3 trial comparing REVAXIS® to DT Polio® as a second booster in 6-year-old children for diphtheria, tetanus, and poliomyelitis; study c…
-
CLINICAL_TRIALS trial_result · 2017-09-11Clinical Trial Update: Antibody Persistence to REVAXIS or DT Polio and Immune Response to TETRAVAC-ACELLULAIRE [Phase 4]
Phase 4 trial update on antibody persistence to REVAXIS or DT polio and immune response to TETRAVAC-ACELLULAIRE completed.
-
CLINICAL_TRIALS trial_result · 2017-09-11Clinical Trial Update: Safety and Immunogenicity Study of Concomitant Versus Non Concomitant Administration of a Diphtheria, Tetanus, Pertussis and Poliomyelitis Vaccine (REPEVAX) and Influenza Vaccine (VAXIGRIP) in Subjects Aged From 60 Years Old [Phase 3]
Phase 3 trial assessing safety and immunogenicity of concomitant vs non-concomitant administration of REPEVAX and VAXIGRIP in adults aged 60…
-
CLINICAL_TRIALS trial_result · 2017-09-11Clinical Trial Update: Safety and Immunogenicity Study of a Diphtheria, Tetanus, Acellular Pertussis and Poliomyelitis Vaccine (REPEVAX) Followed by 2 Doses of a Diphtheria, Tetanus and Poliomyelitis Vaccine (REVAXIS) in Subjects of 40 Years of Age or Older [Phase 3]
Phase 3 safety and immunogenicity update of REPEVAX followed by REVAXIS in adults 40+ years.
-
CLINICAL_TRIALS trial_result · 2017-08-18Clinical Trial Update: Non-inferiority of GSK Biologicals' DTPw-HBV/Hib Compared to Two Formulations of GSK Biologicals' DTPw-HBV/Hib [Phase 3]
Phase 3 trial shows non-inferiority of GSK's DTPw-HBV/Hib vaccine compared to two alternative formulations.
-
CLINICAL_TRIALS trial_result · 2017-08-03Clinical Trial Update: Immunogenicity and Safety of Booster Dose of BoostrixTM Polio Vaccine in Previously Boosted Adults [Phase 4]
Phase 4 trial reporting immunogenicity and safety of a booster dose of Boostrix Polio vaccine in adults previously boosted, with results pos…